In the present minireview, we intend to provide a brief history of the field of CD9 involvement in oncogenesis and in the metastatic process of cancer, considering its potential value as a tumor-associated antigenic target. Over the years, CD9 has been identified as a favorable prognostic marker or predictor of metastatic potential depending on the cancer type. To understand its implications in cancer beside its use as an antigenic biomarker, it is essential to know its physiological functions, including its molecular partners in a given cell system. Moreover, the discovery that CD9 is one of the most specific and broadly expressed markers of extracellular membrane vesicles, nanometer-sized entities that are released into extracellular space and various physiological body fluids and play a role in intercellular communication under physiological and pathological conditions, notably the establishment of cancer metastases, has added a new dimension to our knowledge of CD9 function in cancer. Here, we will discuss these issues as well as the possible cancer therapeutic implications of CD9, their limitations, and pitfalls.
KerseyJHLeBienTWAbramsonCSNewmanRSutherlandRGreavesM.P-24: a human leukemia-associated and lymphohemopoietic progenitor cell surface structure identified with monoclonal antibody. J Exp Med1981;
153:726–31
2.
JonesNHBorowitzMJMetzgarRS.Characterization and distribution of a 24,000-molecular weight antigen defined by a monoclonal antibody (DU-ALL-1) elicited to common acute lymphoblastic leukemia (cALL) cells. Leuk Res1982;
6:449–64
3.
ReyesRCardeñesBMachado-PinedaYCabañasC.Tetraspanin CD9: a key regulator of cell adhesion in the immune system. Front Immunol2018;
9:863
4.
BoucheixCDucGHJasminCRubinsteinE.Tetraspanins and malignancy. Expert Rev Mol Med2001;
2001:1–17
5.
HoriguchiKYoshidaSTsukadaTNakakuraTFujiwaraKHasegawaRTakigamiSOhsakoS.Expression and functions of cluster of differentiation 9 and 81 in rat mammary epithelial cells. J Reprod Dev2020. doi: 10.1262/jrd.2020-082
6.
HemlerME.Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. Annu Rev Cell Dev Biol2003;
19:397–422
7.
Machado-PinedaYCardeñesBReyesRLópez-MartínSToribioVSánchez-OrganeroPSuarezHGrötzingerJLorenzenIYáñez-MóMCabañasC.CD9 controls integrin alpha5beta1-mediated cell adhesion by modulating its association with the metalloproteinase ADAM17. Front Immunol2018;
9:2474
8.
BlakeDJMartiszusJDLoneTHFensterSD.Ablation of the CD9 receptor in human lung cancer cells using CRISPR/cas alters migration to chemoattractants including IL-16. Cytokine2018;
111:567–70
9.
ZöllerM.Tetraspanins: push and pull in suppressing and promoting metastasis. Nat Rev Cancer2009;
9:40–55
10.
HemlerME.Tetraspanin proteins promote multiple cancer stages. Nat Rev Cancer2014;
14:49–60
11.
SeigneuretMDelaguillaumieALagaudriere-GesbertCConjeaudH.Structure of the tetraspanin main extracellular domain. A partially conserved fold with a structurally variable domain insertion. J Biol Chem2001;
276:40055–64
BoucheixCBenoitPFrachetPBillardMWorthingtonREGagnonJUzanG.Molecular cloning of the CD9 antigen. A new family of cell surface proteins. J Biol Chem1991;
266:117–22
14.
BoucheixCRubinsteinE.Tetraspanins. Cell Mol Life Sci2001;
58:1189–205
15.
KovalenkoOVMetcalfDGDeGradoWFHemlerME.Structural organization and interactions of transmembrane domains in tetraspanin proteins. BMC Struct Biol2005;
5:11
16.
StippCSKolesnikovaTVHemlerME.Functional domains in tetraspanin proteins. Trends Biochem Sci2003;
28:106–12
17.
Toyo-OkaKYashiro-OhtaniYParkCSTaiXGMiyakeKHamaokaTFujiwaraH.Association of a tetraspanin CD9 with CD5 on the T cell surface: role of particular transmembrane domains in the association. Int Immunol1999;
11:2043–52
18.
Martín-AlonsoJMHernandoNGhoshSCoca-PradosM.Molecular cloning of the bovine CD9 antigen from ocular ciliary epithelial cells. J Biochem1992;
112:63–7
19.
RubinsteinEBillardMPlaisanceSPrenantMBoucheixC.Molecular cloning of the mouse equivalent of CD9 antigen. Thromb Res1993;
71:377–83
20.
WillettBJNeilJC.cDNA cloning and eukaryotic expression of feline CD9. Mol Immunol1995;
32:417–23
21.
KobayashiT.Molecular cloning and characterization of chick CD9. Kurume Med J2000;
47:151–7
22.
YuberoNJimenez-MarinAYerleMMoreraLBarbanchoMJLlanesDGarridoJJ.Molecular cloning, expression pattern and chromosomal mapping of pig CD9 antigen. Cytogenet Genome Res2003;
101:143–6
23.
XingWJWangLQWuQRenSCBaoXHBouS.Molecular cloning and characterization of CD9 cDNA from sheep and cashmere goat. Reprod Domest Anim2010;
45:383–92
24.
StippCSKolesnikovaTVHemlerME.EWI-2 is a major CD9 and CD81 partner and member of a novel Ig protein subfamily. J Biol Chem2001;
276:40545–54
25.
CharrinSLe NaourFOualidMBillardMFaureGHanashSMBoucheixCRubinsteinE.The major CD9 and CD81 molecular partner. Identification and characterization of the complexes. J Biol Chem2001;
276:14329–37
26.
BerditchevskiF.Complexes of tetraspanins with integrins: more than meets the eye. J Cell Sci2001;
114:4143–51
27.
LevySShohamT.The tetraspanin web modulates immune-signalling complexes. Nat Rev Immunol2005;
5:136–48
28.
ZuidscherwoudeMGottfertFDunlockVMFigdorCGvan den BogaartGvan SprielAB.The tetraspanin web revisited by super-resolution microscopy. Sci Rep2015;
5:12201
29.
SlupskyJRSeehaferJGTangSCMasellis-SmithAShawAR.Evidence that monoclonal antibodies against CD9 antigen induce specific association between CD9 and the platelet glycoprotein IIb-IIIa complex. J Biol Chem1989;
264:12289–93
30.
IndigFEDiaz-GonzalezFGinsbergMH.Analysis of the tetraspanin CD9-integrin alphaIIbbeta3 (GPIIb-IIIa) complex in platelet membranes and transfected cells. Biochem J1997;
327:291–8
31.
LozahicSChristiansenDManieSGerlierDBillardMBoucheixCRubinsteinE.CD46 (membrane cofactor protein) associates with multiple beta1 integrins and tetraspans. Eur J Immunol2000;
30:900–7
32.
OosterheertWXenakiKTNevianiVPosWDoulkeridouSManshandeJPearceNMKroon-BatenburgLMLutzMvan Bergen En HenegouwenPMGrosP.Implications for tetraspanin-enriched microdomain assembly based on structures of CD9 with EWI-F. Life Sci Alliance2020;
3:e202000883
33.
SimonsKIkonenE.Functional rafts in cell membranes. Nature1997;
387:569–72
34.
CharrinSManieSThieleCBillardMGerlierDBoucheixCRubinsteinE.A physical and functional link between cholesterol and tetraspanins. Eur J Immunol2003;
33:2479–89
35.
ClaasCStippCSHemlerME.Evaluation of prototype transmembrane 4 superfamily protein complexes and their relation to lipid rafts. J Biol Chem2001;
276:7974–84
36.
IsraelsSJMcMillan-WardEM.Platelet tetraspanin complexes and their association with lipid rafts. Thromb Haemost2007;
98:1081–7
37.
Sala-ValdésMUrsaACharrinSRubinsteinEHemlerMESánchez-MadridFYáñez-MóM.EWI-2 and EWI-F link the tetraspanin web to the actin cytoskeleton through their direct association with ezrin-radixin-moesin proteins. J Biol Chem2006;
281:19665–75
38.
ZimmermanBKellyBMcMillanBJSeegarTCMDrorROKruseACBlacklowSC.Crystal structure of a full-length human tetraspanin reveals a cholesterol-binding pocket. Cell2016;
167:1041–51
39.
OnoMHandaKSonninoSWithersDANagaiHHakomoriS.GM3 ganglioside inhibits CD9-facilitated haptotactic cell motility: coexpression of GM3 and CD9 is essential in the downregulation of tumor cell motility and malignancy. Biochemistry2001;
40:6414–21
40.
KawakamiYKawakamiKSteelantWFOnoMBaekRCHandaKWithersDAHakomoriS.Tetraspanin CD9 is a "proteolipid," and its interaction with alpha 3 integrin in microdomain is promoted by GM3 ganglioside, leading to inhibition of laminin-5-dependent cell motility. J Biol Chem2002;
277:34349–58
41.
ParkSYYoonSJFreire-de-LimaLKimJHHakomoriSI.Control of cell motility by interaction of gangliosides, tetraspanins, and epidermal growth factor receptor in A431 versus KB epidermoid tumor cells. Carbohydr Res2009;
344:1479–86
42.
CharrinSManieSOualidMBillardMBoucheixCRubinsteinE.Differential stability of tetraspanin/tetraspanin interactions: role of palmitoylation. FEBS Lett2002;
516:139–44
43.
IsraelsSJMcMillan-WardEM.Palmitoylation supports the association of tetraspanin CD63 with CD9 and integrin alphaIIbbeta3 in activated platelets. Thromb Res2010;
125:152–8
44.
YangXHKovalenkoOVKolesnikovaTVAndzelmMMRubinsteinEStromingerJLHemlerME.Contrasting effects of EWI proteins, integrins, and protein palmitoylation on cell surface CD9 organization. J Biol Chem2006;
281:12976–85
45.
Rocha-PeruginiVGonzález-GranadoJMTejeraELópez-MartínSYáñez-MóMSánchez-MadridF.Tetraspanins CD9 and CD151 at the immune synapse support T-cell integrin signaling. Eur J Immunol2014;
44:1967–75
46.
KajiKTakeshitaSMiyakeKTakaiTKudoA.Functional association of CD9 with the Fc gamma receptors in macrophages. J Immunol2001;
166:3256–65
GilsanzASánchez-MartínLGutiérrez-LopezMDOvalleSMachado-PinedaYReyesRSwartGWFigdorCGLafuenteEMCabañasC.ALCAM/CD166 adhesive function is regulated by the tetraspanin CD9. Cell Mol Life Sci2013;
70:475–93
49.
Gutiérrez-LópezMDGilsanzAYáñez-MóMOvalleSLafuenteEMDominguezCMonkPNGonzalez-AlvaroISánchez-MadridFCabañasC.The sheddase activity of ADAM17/TACE is regulated by the tetraspanin CD9. Cell Mol Life Sci2011;
68:3275–92
50.
MünsterbergJLorethDBrylkaLWernerSKarbanováJGandrassMSchneegansSBeslerKHamesterFRobadorJRBauerATSchneiderSWWrageMLamszusKMatschkeJVashistYUzunogluGSteurerSHorstAKOliveira-FerrerLGlatzelMSchinkeTCorbeilDPantelKMaireCWikmanH.ALCAM contributes to brain metastasis formation in non-small-cell lung cancer through interaction with the vascular endothelium. Neuro Oncol2020;
22:955–66
51.
WeidleUHEggleDKlostermannSSwartGW.ALCAM/CD166: cancer-related issues. Cancer Genom Proteom2010;
7:231–43
52.
ShiWFanHShumLDerynckR.The tetraspanin CD9 associates with transmembrane TGF-alpha and regulates TGF-alpha-induced EGF receptor activation and cell proliferation. J Cell Biol2000;
148:591–602
53.
ImhofIGasperWJDerynckR.Association of tetraspanin CD9 with transmembrane TGF{alpha} confers alterations in cell-surface presentation of TGF{alpha} and cytoskeletal organization. J Cell Sci2008;
121:2265–74
54.
MurayamaYShinomuraYOritaniKMiyagawaJYoshidaHNishidaMKatsubeFShiragaMMiyazakiTNakamotoTTsutsuiSTamuraSHigashiyamaSShimomuraIHayashiN.The tetraspanin CD9 modulates epidermal growth factor receptor signaling in cancer cells. J Cell Physiol2008;
216:135–43
55.
RungeKEEvansJEHeZYGuptaSMcDonaldKLStahlbergHPrimakoffPMylesDG.Oocyte CD9 is enriched on the microvillar membrane and required for normal microvillar shape and distribution. Dev Biol2007;
304:317–25
56.
WangHXKolesnikovaTVDenisonCGygiSPHemlerME.The C-terminal tail of tetraspanin protein CD9 contributes to its function and molecular organization. J Cell Sci2011;
124:2702–10
57.
PeñasPFGarcía-DíezASánchez-MadridFYáñez-MóM.Tetraspanins are localized at motility-related structures and involved in normal human keratinocyte wound healing migration. J Invest Dermatol2000;
114:1126–35
58.
BariRGuoQXiaBZhangYHGiesertEELevySZhengJJZhangXA.Tetraspanins regulate the protrusive activities of cell membrane. Biochem Biophys Res Commun2011;
415:619–26
59.
UmedaRSatouhYTakemotoMNakada-NakuraYLiuKYokoyamaTShirouzuMIwataSNomuraNSatoKIkawaMNishizawaTNurekiO.Structural insights into tetraspanin CD9 function. Nat Commun2020;
11:1606
60.
ZhangXAHuangC.Tetraspanins and cell membrane tubular structures. Cell Mol Life Sci2012;
69:2843–52
61.
FranzJBrinkmannBFKonigMHuveJStockCEbnetKRiethmüllerC.Nanoscale imaging reveals a tetraspanin-CD9 coordinated elevation of endothelial ICAM-1 clusters. PLoS One2016;
11:e0146598
62.
RappaGGreenTMKarbanováJCorbeilDLoricoA.Tetraspanin CD9 determines invasiveness and tumorigenicity of human breast cancer cells. Oncotarget2015;
6:7970–91
63.
AbitorabiMAPachynskiRKFerrandoRETidswellMErleDJ.Presentation of integrins on leukocyte microvilli: a role for the extracellular domain in determining membrane localization. J Cell Biol1997;
139:563–71
64.
CharrinSLatilMSoaveSPolesskayaAChrétienFBoucheixCRubinsteinE.Normal muscle regeneration requires tight control of muscle cell fusion by tetraspanins CD9 and CD81. Nat Commun2013;
4:1674
LofflerSLottspeichFLanzaFAzorsaDOter MeulenVSchneider-SchauliesJ.CD9, a tetraspan transmembrane protein, renders cells susceptible to canine distemper virus. J Virol1997;
71:42–9
67.
SingethanKMüllerNSchubertSLüttgeDKrementsovDNKhuranaSRKrohneGSchneider-SchauliesSThaliMSchneider-SchauliesJ.CD9 clustering and formation of microvilli zippers between contacting cells regulates virus-induced cell fusion. Traffic2008;
9:924–35
68.
VjuginaUEvansJP.New insights into the molecular basis of mammalian sperm-egg membrane interactions. Front Biosci2008;
13:462–76
69.
Le NaourFRubinsteinEJasminCPrenantMBoucheixC.Severely reduced female fertility in CD9-deficient mice. Science2000;
287:319–21
70.
KajiKOdaSShikanoTOhnukiTUematsuYSakagamiJTadaNMiyazakiSKudoA.The gamete fusion process is defective in eggs of Cd9-deficient mice. Nat Genet2000;
24:279–82
71.
ChenMSTungKSCoonrodSATakahashiYBiglerDChangAYamashitaYKincadePWHerrJCWhiteJM.Role of the integrin-associated protein CD9 in binding between sperm ADAM 2 and the egg integrin alpha6beta1: implications for murine fertilization. Proc Natl Acad Sci U S A1999;
96:11830–5 USA
72.
JankovičováJNeuerováZSečováPBartókováMBubeníčkováFKomrskováKPostlerováPAntalikováJ.Tetraspanins in mammalian reproduction: spermatozoa, oocytes and embryos. Med Microbiol Immunol2020;
209:407–25
73.
FrolikovaMManaskova-PostlerovaPCernyJJankovicovaJSimonikOPohlovaASecovaPAntalikovaJ.Dvorakova-Hortova K. CD9 and CD81 interactions and their structural modelling in sperm prior to fertilization. Int J Mol Sci2018;
19:1236–52
74.
ZiyyatARubinsteinEMonier-GavelleFBarraudVKulskiOPrenantMBoucheixCBomselMWolfJP.CD9 controls the formation of clusters that contain tetraspanins and the integrin alpha 6 beta 1, which are involved in human and mouse gamete fusion. J Cell Sci2006;
119:416–24
75.
MillerBJGeorges-LabouesseEPrimakoffPMylesDG.Normal fertilization occurs with eggs lacking the integrin alpha6beta1 and is CD9-dependent. J Cell Biol2000;
149:1289–96
76.
MiyadoKYamadaGYamadaSHasuwaHNakamuraYRyuFSuzukiKKosaiKInoueKOguraAOkabeMMekadaE.Requirement of CD9 on the egg plasma membrane for fertilization. Science2000;
287:321–4
77.
BenammarAZiyyatALefevreBWolfJP.Tetraspanins and mouse oocyte microvilli related to fertilizing ability. Reprod Sci2017;
24:1062–9
78.
InoueNSaitoTWadaI.Unveiling a novel function of CD9 in surface compartmentalization of oocytes. Development2020;
147:dev189985
79.
WaterhouseRHaCDvekslerGS.Murine CD9 is the receptor for pregnancy-specific glycoprotein 17. J Exp Med2002;
195:277–82
80.
HaCTWaterhouseRWarrenJZimmermannWDvekslerGS.N-glycosylation is required for binding of murine pregnancy-specific glycoproteins 17 and 19 to the receptor CD9. Am J Reprod Immunol2008;
59:251–8
81.
QiJCWangJMandadiSTanakaKRoufogalisBDMadiganMCLaiKYanFChongBHStevensRLKrilisSA.Human and mouse mast cells use the tetraspanin CD9 as an alternate interleukin-16 receptor. Blood2006;
107:135–42
82.
YadavSShiYWangH.IL-16 effects on A549 lung epithelial cells: dependence on CD9 as an IL-16 receptor?J Immunotoxicol2010;
7:183–93
83.
IwamotoRHigashiyamaSMitamuraTTaniguchiNKlagsbrunMMekadaE.Heparin-binding EGF-like growth factor, which acts as the diphtheria toxin receptor, forms a complex with membrane protein DRA. P27/CD9, which up-regulates functional receptors and diphtheria toxin sensitivity. EMBO J1994;
13:2322–30
84.
EarnestJTHantakMPLiKMcCrayPBJr.PerlmanSGallagherT.The tetraspanin CD9 facilitates MERS-coronavirus entry by scaffolding host cell receptors and proteases. PLoS Pathog2017;
13:e1006546
85.
AndreuZYáñez-MóM.Tetraspanins in extracellular vesicle formation and function. Front Immunol2014;
5:442
86.
RappaGGreenTMLoricoA.The nuclear Pool of tetraspanin CD9 contributes to mitotic processes in human breast carcinoma. Mol Cancer Res2014;
12:1840–50
87.
WeiPWuFKangBSunXHeskiaFPachotALiangJLiD.Plasma extracellular vesicles detected by single molecule array technology as a liquid biopsy for colorectal cancer. J Extracell Vesicles2020;
9:1809765
88.
HoshinoAKimHSBojmarLGyanKECioffiMHernandezJZambirinisCPRodriguesGMolinaHHeisselSMarkMTSteinerLBenito-MartinALucottiSDi GiannataleAOfferKNakajimaMWilliamsCNoguesLPelissier VatterFAHashimotoADaviesAEFreitasDKenificCMArarsoYBuehringWLauritzenPOgitaniYSugiuraKTakahashiNAleckovicMBaileyKAJolissantJSWangHHarrisASchaefferLMGarcia-SantosGPosnerZBalachandranVPKhakooYRajuGPScherzASagiIScherz-ShouvalRYardenYOrenMMalladiMPetriccioneMDe BragancaKCDonzelliMFischerCVitolanoSWrightGPGanshawLMarranoMAhmedADeStefanoJDanzerERoehrlMHALacayoNJVincentTCWeiserMRBradyMSMeyersPAWexlerLHAmbatiSRChouAJSlotkinEKModakSRobertsSSBasuEMDiolaitiDKrantzBACardosoFSimpsonALBergerMRudinCMSimeoneDMJainMGhajarCMBatraSKStangerBZBuiJBrownKARajasekharVKHealeyJHde SousaMKramerKShethSBaischJPascualVHeatonTELa QuagliaMPPisapiaDJSchwartzRZhangHLiuYShuklaABlavierLDeClerckYALaBargeMBissellMJCaffreyTCGrandgenettPMHollingsworthMABrombergJCosta-SilvaBPeinadoHKangYGarciaBAO'ReillyEMKelsenDTrippettTMJonesDRMateiIRJarnaginWRLydenD.Extracellular vesicle and particle biomarkers define multiple human cancers. Cell2020;
182:1044–61
89.
DingXQWangZYXiaDWangRXPanXRTongJH.Proteomic profiling of serum exosomes from patients with metastatic gastric cancer. Front Oncol2020;
10:1113
90.
RaposoGStoorvogelW.Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol2013;
200:373–83
91.
CiardielloCCavalliniLSpinelliCYangJReis-SobreiroMde CandiaPMinciacchiVRDi VizioD.Focus on extracellular vesicles: new frontiers of cell-to-cell communication in cancer. Int J Mol Sci2016;
17:175
92.
CorbeilDLoricoA.Exosomes, microvesicles, and their friends in solid tumors. In: LEdelsteinJSmythiesPQuesenberryDNoble (eds) Exosomes: a clinical compendium.
Cambridge, MA:
Academic Press, 2020, Chapter
3, pp.39–80
93.
van NielGD'AngeloGRaposoG.Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol2018;
19:213–28
94.
TkachMThéryC.Communication by extracellular vesicles: where we are and where we need to go. Cell2016;
164:1226–32
95.
BuzasEIGyorgyBNagyGFalusAGayS.Emerging role of extracellular vesicles in inflammatory diseases. Nat Rev Rheumatol2014;
10:356–64
96.
WangYZhaoMLiuSGuoJLuYChengJLiuJ.Macrophage-derived extracellular vesicles: diverse mediators of pathology and therapeutics in multiple diseases. Cell Death Dis2020;
11:924
97.
FuSZhangYLiYLuoLZhaoYYaoY.Extracellular vesicles in cardiovascular diseases. Cell Death Discov2020;
6:68
RatajczakJWysoczynskiMHayekFJanowska-WieczorekARatajczakMZ.Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia2006;
20:1487–95
100.
ValadiHEkströmKBossiosASjöstrandMLeeJJLötvallJO.Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol2007;
9:654–9
101.
UllahMQiaoYConcepcionWThakorAS.Stem cell-derived extracellular vesicles: role in oncogenic processes, bioengineering potential, and technical challenges. Stem Cell Res Ther2019;
10:347
102.
SoekmadjiCRichesJDRussellPJRuelckeJEMcPhersonSWangCHovensCMCorcoranNM.Australian prostate cancer collaboration B, hill MM, Nelson CC. Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer. Oncotarget2017;
8:52237–55
103.
SoekmadjiCCorcoranNMOleinikovaIJovanovicLAustralian Prostate Cancer CollaborationBRammGANelsonCCJensterGRussellPJ.Extracellular vesicles for personalized therapy decision support in advanced metastatic cancers and its potential impact for prostate cancer. Prostate2017;
77:1416–23
104.
InubushiSKawaguchiHMizumotoSKunihisaTBabaMKitayamaYTakeuchiTHoffmanRMTaninoHSasakiR.Oncogenic miRNAs identified in tear exosomes from metastatic breast cancer patients. Anticancer Res2020;
40:3091–6
FujitaYYoshiokaYOchiyaT.Extracellular vesicle transfer of cancer pathogenic components. Cancer Sci2016;
107:385–90
107.
XuRRaiAChenMSuwakulsiriWGreeningDWSimpsonRJ.Extracellular vesicles in cancer - implications for future improvements in cancer care. Nat Rev Clin Oncol2018;
15:617–38
108.
KowalJArrasGColomboMJouveMMorathJPPrimdal-BengtsonBDingliFLoewDTkachMThéryC.Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc Natl Acad Sci U S A2016;
113:E968–77
109.
RappaGSantosMFGreenTMKarbanováJHasslerJBaiYBarskySHCorbeilDLoricoA.Nuclear transport of cancer extracellular vesicle-derived biomaterials through nuclear envelope invagination-associated late endosomes. Oncotarget2017;
8:14443–61
110.
CaballeroJNFrenetteGBelleanneeCSullivanR.CD9-positive microvesicles mediate the transfer of molecules to bovine spermatozoa during epididymal maturation. PLoS One2013;
8:e65364
111.
MiyadoKYoshidaKYamagataKSakakibaraKOkabeMWangXMiyamotoKAkutsuHKondoTTakahashiYBanTItoCToshimoriKNakamuraAItoMMiyadoMMekadaEUmezawaA.The fusing ability of sperm is bestowed by CD9-containing vesicles released from eggs in mice. Proc Natl Acad Sci U S A2008;
105:12921–6
112.
ChairoungduaASmithDLPochardPHullMCaplanMJ.Exosome release of beta-catenin: a novel mechanism that antagonizes wnt signaling. J Cell Biol2010;
190:1079–91
113.
MazurovDBarbashovaLFilatovA.Tetraspanin protein CD9 interacts with metalloprotease CD10 and enhances its release via exosomes. FEBS J2013;
280:1200–13
114.
BuschowSINolte-'t HoenENvan NielGPolsMSten BroekeTLauwenMOssendorpFMeliefCJRaposoGWubboltsRWaubenMHStoorvogelW.MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways. Traffic2009;
10:1528–42
115.
HouleCDDingXYFoleyJFAfshariCABarrettJCDavisBJ.Loss of expression and altered localization of KAI1 and CD9 protein are associated with epithelial ovarian cancer progression. Gynecol Oncol2002;
86:69–78
116.
MhawechPDulguerovPTschanzEVerdanCAresCAllalAS.Motility-related protein-1 (MRP-1/CD9) expression can predict disease-free survival in patients with squamous cell carcinoma of the head and neck. Br J Cancer2004;
90:471–5
117.
SantosMFRappaGKarbanováJKurthTCorbeilDLoricoA.VAMP-associated protein-A and oxysterol-binding protein-related protein 3 promote the entry of late endosomes into the nucleoplasmic reticulum. J Biol Chem2018;
293:13834–48
118.
CorbeilDSantosMFKarbanováJKurthTRappaGLoricoA.Uptake and fate of extracellular vesicles: nucleoplasmic reticulum-associated late endosomes as a new gate to intercellular communication. Cells2020;
9:1931–58
119.
LevinaEJiHChenMBaigMOliverDOhouoPLimCUSchoolsGCarmackSDingYBroudeEVRoninsonIBButtyanRShtutmanM.Identification of novel genes that regulate androgen receptor signaling and growth of androgen-deprived prostate cancer cells. Oncotarget2015;
6:13088–104
120.
BrosseauCColasLMagnanABrouardSC.Tetraspanin A new pathway for the regulation of inflammation?Front Immunol2018;
9:2316
121.
CharrinSJouannetSBoucheixCRubinsteinE.Tetraspanins at a glance. J Cell Sci2014;
127:3641–8
122.
BaekJJangNChoiJEKimJRBaeYK.CD9 expression in tumor cells is associated with poor prognosis in patients with invasive lobular carcinoma. J Breast Cancer2019;
22:77–85
123.
SchaperFvan SprielAB.Antitumor immunity is controlled by tetraspanin proteins. Front Immunol2018;
9:1185
124.
HoltanSGCreedonDJThompsonMANevalaWKMarkovicSN.Expansion of CD16-negative natural killer cells in the peripheral blood of patients with metastatic melanoma. Clin Dev Immunol2011;
2011:316314
125.
SunJWangJPefanisEChaoJRothschildGTachibanaIChenJKIvanovIIRabadanRTakedaYBasuU.Transcriptomics identify CD9 as a marker of murine IL-10-competent regulatory B cells. Cell Rep2015;
13:1110–7
WangJCBeginLRBerubeNGChevalierSAprikianAGGourdeauHChevretteM.Down-regulation of CD9 expression during prostate carcinoma progression is associated with CD9 mRNA modifications. Clin Cancer Res2007;
13:2354–61
128.
ChuanYPangSTBerghANorstedtGPousetteA.Androgens induce CD-9 in human prostate tissue. Int J Androl2005;
28:291–6
129.
CopelandBTBowmanMJBoucheixCAshmanLK.Knockout of the tetraspanin Cd9 in the TRAMP model of de novo prostate cancer increases spontaneous metastases in an organ-specific manner. Int J Cancer2013;
133:1803–12
130.
SaitoYTachibanaITakedaYYamaneHHePSuzukiMMinamiSKijimaTYoshidaMKumagaiTOsakiTKawaseI.Absence of CD9 enhances adhesion-dependent morphologic differentiation, survival, and matrix metalloproteinase-2 production in small cell lung cancer cells. Cancer Res2006;
66:9557–65
131.
TakedaTHattoriNTokuharaTNishimuraYYokoyamaMMiyakeM.Adenoviral transduction of MRP-1/CD9 and KAI1/CD82 inhibits lymph node metastasis in orthotopic lung cancer model. Cancer Res2007;
67:1744–9
132.
IkeyamaSKoyamaMYamaokoMSasadaRMiyakeM.Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA. J Exp Med1993;
177:1231–7
133.
FunakoshiTTachibanaIHoshidaYKimuraHTakedaYKijimaTNishinoKGotoHYonedaTKumagaiTOsakiTHayashiSAozasaKKawaseI.Expression of tetraspanins in human lung cancer cells: frequent downregulation of CD9 and its contribution to cell motility in small cell lung cancer. Oncogene2003;
22:674–87
134.
OvalleSGutiérrez-LópezMDOlmoNTurnayJLizarbeMAMajanoPMolina-JiménezFLópez-CabreraMYáñez-MóMSánchez-MadridFCabañasC.The tetraspanin CD9 inhibits the proliferation and tumorigenicity of human colon carcinoma cells. Int J Cancer2007;
121:2140–52
135.
CajotJFSordatISilvestreTSordatB.Differential display cloning identifies motility-related protein (MRP1/CD9) as highly expressed in primary compared to metastatic human colon carcinoma cells. Cancer Res1997;
57:2593–7
136.
BondDRKahlRBrzozowskiJSJankowskiHNaudinCPariyarMAvery-KiejdaKAScarlettCJBoucheixCMullerWJAshmanLKCairnsMJRoselliSWeidenhoferJ.Tetraspanin CD9 is regulated by miR-518f-5p and functions in breast cell migration and in vivo tumor growth. Cancers2020;
12:795
137.
PownerDKoppPMMonkleySJCritchleyDRBerditchevskiF.Tetraspanin CD9 in cell migration. Biochem Soc Trans2011;
39:563–7
138.
MiyakeMNakanoKIekiYAdachiMHuangCLItoiSKohTTakiT.Motility related protein 1 (MRP-1/CD9) expression: inverse correlation with metastases in breast cancer. Cancer Res1995;
55:4127–31
139.
MiyakeMNakanoKItoiSIKohTTakiT.Motility-related protein-1 (MRP-1/CD9) reduction as a factor of poor prognosis in breast cancer. Cancer Res1996;
56:1244–9
140.
MimoriKKataokaAYoshinagaKOhtaMSagaraYYoshikawaYOhnoSBarnardGFMoriM.Identification of molecular markers for metastasis-related genes in primary breast cancer cells. Clin Exp Metastasis2005;
22:59–67
141.
HuangCIKohnoNOgawaEAdachiMTakiTMiyakeM.Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients. Am J Pathol1998;
153:973–83
142.
ShoMAdachiMTakiTHashidaHKonishiTHuangCLIkedaNNakajimaYKanehiroHHisanagaMNakanoHMiyakeM.Transmembrane 4 superfamily as a prognostic factor in pancreatic cancer. Int J Cancer1998;
79:509–16
143.
AmatyaVJTakeshimaYAoeKFujimotoNOkamotoTYamadaTKishimotoTMorimotoCInaiK.CD9 expression as a favorable prognostic marker for patients with malignant mesothelioma. Oncol Rep2013;21–29
144.
OkamotoTIwataSYamazakiHHatanoRKomiyaEDangNHOhnumaKMorimotoC.CD9 negatively regulates CD26 expression and inhibits CD26-mediated enhancement of invasive potential of malignant mesothelioma cells. PLoS One2014;
9:e86671
145.
BrzozowskiJSBondDRJankowskiHGoldieBJBurchellRNaudinCSmithNDScarlettCJLarsenMRDunMDSkeldingKAWeidenhoferJ.Extracellular vesicles with altered tetraspanin CD9 and CD151 levels confer increased prostate cell motility and invasion. Sci Rep2018;
8:8822
146.
HoriHYanoSKoufujiKTakedaJShirouzuK.CD9 expression in gastric cancer and its significance. J Surg Res2004;
117:208–15
147.
MikiYYashiroMOkunoTKitayamaKMasudaGHirakawaKOhiraM.CD9-positive exosomes from cancer-associated fibroblasts stimulate the migration ability of scirrhous-type gastric cancer cells. Br J Cancer2018;
118:867–77
148.
KischelPBellahceneADeuxBLamourVDobsonRDepEClezardinPCastronovoV.Overexpression of CD9 in human breast cancer cells promotes the development of bone metastases. Anticancer Res2012;
32:5211–20
149.
KwonHJChoiJEKangSHSonYBaeYK.Prognostic significance of CD9 expression differs between tumour cells and stromal immune cells, and depends on the molecular subtype of the invasive breast carcinoma. Histopathology2017;
70:1155–65
150.
HwangJRJoKLeeYSungBJParkYWLeeJH.Upregulation of CD9 in ovarian cancer is related to the induction of TNF-alpha gene expression and constitutive NF-kappaB activation. Carcinogenesis2012;
33:77–83
151.
PetersDGKudlaDMDeloiaJAChuTJFairfullLEdwardsRPFerrellRE.Comparative gene expression analysis of ovarian carcinoma and normal ovarian epithelium by serial analysis of gene expression. Cancer Epidemiol Biomarkers Prev2005;
14:1717–23
152.
DrapkinRCrumCPHechtJL.Expression of candidate tumor markers in ovarian carcinoma and benign ovary: evidence for a link between epithelial phenotype and neoplasia. Hum Pathol2004;
35:1014–21
153.
KovalenkoOVYangXHHemlerME.A novel cysteine cross-linking method reveals a direct association between claudin-1 and tetraspanin CD9. Mol Cell Proteom2007;
6:1855–67
154.
ZhouBMoodieABlanchardAALeygueEMyalY.Claudin 1 in breast cancer: new insights. J Clin Med2015;
4:1960–76
155.
OkuNSasabeEUetaEYamamotoTOsakiT.Tight junction protein claudin-1 enhances the invasive activity of oral squamous cell carcinoma cells by promoting cleavage of laminin-5 gamma2 chain via matrix metalloproteinase (MMP)-2 and membrane-type MMP-1. Cancer Res2006;
66:5251–7
156.
TakebeNWarrenRQIvySP.Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition. Breast Cancer Res2011;
13:211
157.
QuailDFJoyceJA.Microenvironmental regulation of tumor progression and metastasis. Nat Med2013;
19:1423–37
158.
MacheskyLM.Lamellipodia and filopodia in metastasis and invasion. FEBS Lett2008;
582:2102–11
159.
KhuonSLiangLDettmanRWSpornPHWysolmerskiRBChewTL.Myosin light chain kinase mediates transcellular intravasation of breast cancer cells through the underlying endothelial cells: a three-dimensional FRET study. J Cell Sci2010;
123:431–40
160.
UllahMAkbarANgNNConcepcionWThakorAS.Mesenchymal stem cells confer chemoresistance in breast cancer via a CD9 dependent mechanism. Oncotarget2019;
10:3435–50
161.
UllahMAkbarAThakorAS.An emerging role of CD9 in stemness and chemoresistance. Oncotarget2019;
10:4000–1
162.
HeusermannWHeanJTrojerDSteibEvon BuerenSGraff-MeyerAGenoudCMartinKPizzatoNVosholJMorrisseyDVAndaloussiSEWoodMJMeisner-KoberNC.Exosomes surf on filopodia to enter cells at endocytic hot spots, traffic within endosomes, and are targeted to the ER. J Cell Biol2016;
213:173–84
163.
RomanskaHMBerditchevskiF.Tetraspanins in human epithelial malignancies. J Pathol2011;
223:4–14
164.
ArihiroKKanekoMFujiiSInaiK.Loss of CD9 with expression of CD31 and VEGF in breast carcinoma, as predictive factors of lymph node metastasis. Breast Cancer1998;
5:131–8
165.
JamilFPestonDShoushaS.CD9 immunohistochemical staining of breast carcinoma: unlikely to provide useful prognostic information for routine use. Histopathology2001;
39:572–7
166.
HemlerME.Targeting of tetraspanin proteins–potential benefits and strategies. Nat Rev Drug Discov2008;
7:747–58
167.
BetrianSYsebaertLHeiderKHDelordJPFournieJJQuillet-MaryA.Idelalisib improves CD37 antibody BI 836826 cytotoxicity against chemo-resistant/relapse-initiating CLL cells: a rationale for combination treatment. Blood Cancer J2016;
6:e496
168.
HicksSWLaiKCGavrilescuLCYiYSikkaSShahPKellyMELeeJLanieriLPonteJFSlossCMRomanelliA.The antitumor activity of IMGN529, a CD37-targeting antibody-drug conjugate, is potentiated by rituximab in non-Hodgkin lymphoma models. Neoplasia2017;
19:661–71
169.
ZhuGZMillerBJBoucheixCRubinsteinELiuCCHynesROMylesDGPrimakoffP.Residues SFQ (173-175) in the large extracellular loop of CD9 are required for gamete fusion. Development2002;
129:1995–2002
170.
HigginbottomATakahashiYBollingLCoonrodSAWhiteJMPartridgeLJMonkPN.Structural requirements for the inhibitory action of the CD9 large extracellular domain in sperm/oocyte binding and fusion. Biochem Biophys Res Commun2003;
311:208–14
171.
HoSHMartinFHigginbottomAPartridgeLJParthasarathyVMoseleyGWLopezPCheng-MayerCMonkPN.Recombinant extracellular domains of tetraspanin proteins are potent inhibitors of the infection of macrophages by human immunodeficiency virus type 1. J Virol2006;
80:6487–96
172.
MurayamaYOritaniKTsutsuiS.Novel CD9-targeted therapies in gastric cancer. World J Gastroenterol2015;
21:3206–13
173.
Gutiérrez-LópezMDOvalleSYáñez-MóMSánchez-SánchezNRubinsteinEOlmoNLizarbeMASánchez-MadridFCabañasC.A functionally relevant conformational epitope on the CD9 tetraspanin depends on the association with activated beta1 integrin. J Biol Chem2003;
278:208–18
174.
VasseMColinSGuilmainWCreoffEMuraineMVannierJPAl-MahmoodS.[Tetraspanins: a new target for antiangiogenic therapy?]Ann Pharm Fr2015;
73:100–7
175.
IwasakiTTakedaYMaruyamaKYokosakiYTsujinoKTetsumotoSKuharaHNakanishiKOtaniYJinYKohmoSHirataHTakahashiRSuzukiMInoueKNagatomoIGoyaSKijimaTKumagaiTTachibanaIKawaseIKumanogohA.Deletion of tetraspanin CD9 diminishes lymphangiogenesis in vivo and in vitro. J Biol Chem2013;
288:2118–31
176.
Klein-SoyerCAzorsaDOCazenaveJPLanzaF.CD9 participates in endothelial cell migration during in vitro wound repair. Arterioscler Thromb Vasc Biol2000;
20:360–9
177.
BoucheixCSoriaCMirshahiMSoriaJPerrotJYFournierNBillardMRosenfeldC.Characteristics of platelet aggregation induced by the monoclonal antibody ALB6 (acute lymphoblastic leukemia antigen p 24). Inhibition of aggregation by ALB6Fab. FEBS Lett1983;
161:289–95
178.
NakamotoTMurayamaYOritaniKBoucheixCRubinsteinENishidaMKatsubeFWatabeKKisoSTsutsuiSTamuraSShinomuraYHayashiN.A novel therapeutic strategy with anti-CD9 antibody in gastric cancers. J Gastroenterol2009;
44:889–96
179.
KamisasanukiTTokushigeSTerasakiHKhaiNCWangYSakamotoTKosaiK.Targeting CD9 produces stimulus-independent antiangiogenic effects predominantly in activated endothelial cells during angiogenesis: a novel antiangiogenic therapy. Biochem Biophys Res Commun2011;
413:128–35
180.
LongoNYáñez-MóMMittelbrunnMde la RosaGMuñozMLSánchez-MadridFSánchez-MateosP.Regulatory role of tetraspanin CD9 in tumor-endothelial cell interaction during transendothelial invasion of melanoma cells. Blood2001;
98:3717–26
181.
ColinSGuilmainWCreoffESchneiderCSteverlynckCBongaertsMLegrandEVannierJPMuraineMVasseMAl-MahmoodSA.Truncated form of CD9-partner 1 (CD9P-1), GS-168AT2, potently inhibits in vivo tumour-induced angiogenesis and tumour growth. Br J Cancer2011;
105:1002–11
182.
MurayamaYMiyagawaJOritaniKYoshidaHYamamotoKKishidaOMiyazakiTTsutsuiSKiyoharaTMiyazakiYHigashiyamaSMatsuzawaYShinomuraY.CD9-mediated activation of the p46 shc isoform leads to apoptosis in cancer cells. J Cell Sci2004;
117:3379–88
183.
ShallalSKornbluthJ.CD9 expression enhances the susceptibility of myeloma cell lines to cell-mediated cytolysis. Blood2000;
96:224–33
184.
SantosMFRappaGKarbanováJVanierCMorimotoCCorbeilDLoricoA.Anti-human CD9 antibody fab fragment impairs the internalization of extracellular vesicles and the nuclear transfer of their cargo proteins. J Cell Mol Med2019;
23:4408–21
185.
LetarteMSeehaferJGGreavesAMasellis-SmithAShawAR.Homotypic aggregation of pre-B leukemic cell lines by antibodies to VLA integrins correlates with their expression of CD9. Leukemia1993;
7:93–103
186.
Oude MunninkTHHenstraMJSegerinkLIMovigKLBrummelhuis-VisserP.Therapeutic drug monitoring of monoclonal antibodies in inflammatory and malignant disease: translating TNF-alpha experience to oncology. Clin Pharmacol Ther2016;
99:419–31
187.
RubinsteinEBoucheixCWorthingtonRECarrollRC.Anti-platelet antibody interactions with Fc gamma receptor. Semin Thromb Hemost1995;
21:10–22
188.
BlairTAMichelsonADFrelingerAL.3rd Mass cytometry reveals distinct platelet subtypes in healthy subjects and novel alterations in surface glycoproteins in glanzmann thrombasthenia. Sci Rep2018;
8:10300
189.
KaprielianZChoKOHadjiargyrouMPattersonPH.CD9, a major platelet cell surface glycoprotein, is a ROCA antigen and is expressed in the nervous system. J Neurosci1995;
15:562–73
190.
CarrollRCRubinsteinEWorthingtonREBoucheixC.Extensive C1q-complement initiated lysis of human platelets by IgG subclass murine monoclonal antibodies to the CD9 antigen. Thromb Res1990;
59:831–9
191.
HigashiharaMMaedaHShibataYKumeSOhashiT.A monoclonal anti-human platelet antibody: a new platelet aggregating substance. Blood1985;
65:382–91
192.
MillerJLKupinskiJMHustadKO.Characterization of a platelet membrane protein of low molecular weight associated with platelet activation following binding by monoclonal antibody AG-1. Blood1986;
68:743–51
193.
HatoTIkedaKYasukawaMWatanabeAKobayashiY.Exposure of platelet fibrinogen receptors by a monoclonal antibody to CD9 antigen. Blood1988;
72:224–9
194.
JenningsLKFoxCFKounsWCMcKayCPBallouLRSchultzHE.The activation of human platelets mediated by anti-human platelet p24/CD9 monoclonal antibodies. J Biol Chem1990;
265:3815–22
195.
IsraelsSJMcMillan-WardEMEastonJRobertsonCMcNicolA.CD63 associates with the alphaIIb beta3 integrin-CD9 complex on the surface of activated platelets. Thromb Haemost2001;
85:134–41
196.
WorthingtonRECarrollRCBoucheixC.Platelet activation by CD9 monoclonal antibodies is mediated by the Fc gamma II receptor. Br J Haematol1990;
74:216–22
197.
KawakatsuTSuzukiMKidoHSakaneHHadaSYamaguchiKFukuroiTYanabuMNagataHNomuraSKokawaTYasunagaK.Antithrombotic effect of an anti-glycoprotein IIB/IIIA antibody in primate lethal thrombosis. Thromb Res1993;
70:245–54
198.
De JongGLevieSESchotteRPosWGoDYasudaECercelMvan Hal-van VeenSEFrankinESzabóAVillaudyJvan HeldenPMvan EenennaamHSpitsHRijneveldAHazenbergMD.AT1412, a patient-derived antibody in development for the treatment of CD9 positive precursor B-acute lymphoblastic leukemia. Blood2019;
134:4461
199.
NevianiVvan DeventerSWornerTPXenakiKTvan de WaterbeemdMRodenburgRNPWortelIMNKuiperJKHuismanSGrannemanJvan Bergen En HenegouwenPMPHeckAJRvan SprielABGrosP.Site-specific functionality and tryptophan mimicry of lipidation in tetraspanin CD9. FEBS J2020. doi: 10.1111/febs.15295
200.
VillaudyJSchotteRGdJNevianiVPosWLevieSYasudaECercelMSzabóAFatmawatiCKeddeMHorbachSVerdegaalEMEPvHSHvdBRijneveldAGrosPSpitsHHazenbergMHvE.Preclinical development of AT1412, a patient derived CD9 antibody that does not induce thrombosis for treatment of precursor B ALL. Ann Oncol2020;
31:S493
201.
SchotteRVillaudyJKeddeMPosWWagnerKGoDFatmawatiCMoisetGYasudaECercelMFrankinESvH-VVPvHVerdegaalEMEHvE.Burg SHvd, spits H. 580P AT1412, a patient-derived CD9 antibody promotes tumour immune infiltration and induces tumour rejection. Ann Oncol2020;
31:S492
202.
ChambrionCLe NaourF.The tetraspanins CD9 and CD81 regulate CD9P1-induced effects on cell migration. PLoS One2010;
5:e11219
203.
PeinadoHAlečkovićMLavotshkinSMateiICosta-SilvaBMoreno-BuenoGHergueta-RedondoMWilliamsCGarcía-SantosGGhajarCNitadori-HoshinoAHoffmanCBadalKGarciaBACallahanMKYuanJMartinsVRSkogJKaplanRNBradyMSWolchokJDChapmanPBKangYBrombergJLydenD.Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med2012;
18:883–91
204.
OnoMHandaKWithersDAHakomoriS.Motility inhibition and apoptosis are induced by metastasis-suppressing gene product CD82 and its analogue CD9, with concurrent glycosylation. Cancer Res1999;
59:2335–9
205.
ZhaoLJFanQQLiYYRenHMZhangTLiuSMaaMZhengYCLiuHM.LSD1 deletion represses gastric cancer migration by upregulating a novel miR-142-5p target protein CD9. Pharmacol Res2020;
159:104991
206.
LiYYuSLiLChenJQuanMLiQGaoY.KLF4-mediated upregulation of CD9 and CD81 suppresses hepatocellular carcinoma development via JNK signaling. Cell Death Dis2020;
11:299
207.
ChenSSunYJinZJingX.Functional and biochemical studies of CD9 in fibrosarcoma cell line. Mol Cell Biochem2011;
350:89–99
208.
SauerGWindischJKurzederCHeilmannVKreienbergRDeisslerH.Progression of cervical carcinomas is associated with down-regulation of CD9 but strong local re-expression at sites of transendothelial invasion. Clin Cancer Res2003;
9:6426–31
209.
HigashiyamaMTakiTIekiYAdachiMHuangCLKohTKodamaK, Doi O. Miyake M.
Reduced motility related protein-1 (MRP-1/CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer. Cancer Res1995;
55:6040–4
210.
Gustafson-WagnerEStippCS.The CD9/CD81 tetraspanin complex and tetraspanin CD151 regulate alpha3beta1 integrin-dependent tumor cell behaviors by overlapping but distinct mechanisms. PLoS One2013;
8:e61834
211.
WangVMFerreiraRMMAlmagroJEvanTLegraveNZaw ThinMFrithDCarvalhoJBarryDJSnijdersAPHerbertENyeELMacRaeJIBehrensA.CD9 identifies pancreatic cancer stem cells and modulates glutamine metabolism to fuel tumour growth. Nat Cell Biol2019;
21:1425–35
212.
De BruyneEAndersenTLDe RaeveHVan ValckenborghECaersJVan CampBDelaisseJMVan RietIVanderkerkenK.Endothelial cell-driven regulation of CD9 or motility-related protein-1 expression in multiple myeloma cells within the murine 5T33MM model and myeloma patients. Leukemia2006;
20:1870–9
213.
LeungKTZhangCChanKYYLiKCheungJTKNgMHLZhangXBSitTLeeWYWKangWToKFYuJWSManTKFWangHTsangKSChengFWTLamGKSChowTWLeungAWKLeungTFYuenPMPNgPC, LC.
CD9 blockade suppresses disease progression of high-risk pediatric B-cell precursor acute lymphoblastic leukemia and enhances chemosensitivity. Leukemia2020;
34:709–20
